Connect with us

Cannabis

Yield Growth Launches Shopify Online Store to Bolster Direct to Consumer Sales

Newsfile

Published

on

Vancouver, British Columbia–(Newsfile Corp. – July 22, 2020) – The Yield Growth Corp. (CSE: BOSS) (OTCQB: BOSQF) (FSE: YG3) (“Yield Growth” or the “Company”) is pleased to announce the launch of its new e-commerce website for subsidiary brand, Urban Juve, powered by leading ecommerce platform, Shopify.

Cannot view this image? Visit: https://i0.wp.com/grassnews.net/wp-content/uploads/2020/07/yield-growth-launches-shopify-online-store-to-bolster-direct-to-consumer-sales.jpg?w=740&ssl=1

Yield Growth Launches Shopify Online Store to Bolster Direct to Consumer Sales

To view an enhanced version of this graphic, please visit:
https://orders.newsfilecorp.com/files/6377/60253_boss2.jpg

The online store features the complete Urban Juve plant-based collection as well as select other products, such as Antler’s natural deodorant for men and Urban Juve’s hand sanitizers.

The optimized online store offers a seamless browsing and purchase experience, richer and more robust product content, a range of payment options including Paypal and Apple Pay, as well as key post-purchase automations and marketing programs designed to increase repeat sales.

“Launching a refreshed and optimized ecommerce site is a key strategic project for Urban Juve. It not only improves the customers’ experience with our brand, but is a solid platform upon which we can now develop and expand conversion-driven marketing programs such as influencer and affiliate programs, subscription models, and more,” said Karla Cheon, Vice President of Marketing for Yield Growth. “This initiative, combined with web traffic-generation efforts, will provide quality customer data for Urban Juve to nurture its loyal and growing customer base who are seeking plant-based alternatives for their skin.”

The launch of the optimized UrbanJuve.com on Shopify, the launch of Urban Juve on Amazon.ca and the soon to launch Amazon.com listings are key components of the Company’s strategic plan to invest in and grow direct to consumer sales.

The Company is pleased to offer a 15% discount (using code: INVESTOR15) in celebration of the launch, valid until July 31st, 2020.

Shopify has become the second largest online shopping destination second only to Amazon, as reported by The Observer in September 2019.

The U.S. department of commerce reported that retail e-commerce sales for the first quarter of 2020 reached $146.6 billion, an increase of 14.5% when compared to the first quarter of 2019.

Consumers spent $601.75 billion online with U.S. merchants in 2019, up 14.9% from $523.64 billion in 2018, also according to the U.S. Department of Commerce. This is an increase over 2018’s growth, which was up 13.6% from 2017.

About The Yield Growth Corp.

The Yield Growth Corp. is a phytoceutical and consumer packaged goods company that develops and acquires intellectual property and other assets related to plant-based products and therapeutics, and develops, manufactures, markets, sells and distributes plant-based products. It has over 200 proprietary wellness formulas at various stages of commercialization, with over 20 products, including a hand sanitizer, that are now for sale through e-commerce or brick and mortar retail stores. It has 14 patent applications to protect its extraction methods and wellness formulas and it is in the early stages of research and development of plant based topicals for prevention or treatment of infectious disease. The Global Wellness Institute reports the global wellness industry is a $4.2 trillion-dollar global wellness market. Its majority owned subsidiary NeonMind Biosciences Inc. is launching a line of medicinal mushroom products and is developing intellectual property in the emerging area of psychedelic medicine. The Yield Growth management team has deep experience with global brands including Johnson & Johnson, Procter & Gamble, Skechers and Aritzia.

Investor Relations Contacts:

Penny White, President & CEO

Kevan Matheson, Investor Relations

invest@yieldgrowth.com

1-833-514-BOSS 1-833-514-2677

1-833-515-BOSS 1-833-515-2677

The Canadian Securities Exchange has not reviewed, approved or disapproved the contents of this news release.

Cautionary Statement Regarding Forward-Looking Statements

This press release includes forward-looking information and statements (collectively, “forward looking statements”) under applicable Canadian securities legislation. Forward-looking statements are necessarily based upon a number of estimates, forecasts, beliefs and assumptions that, while considered reasonable, are subject to known and unknown risks, uncertainties, and other factors which may cause actual results and future events to differ materially from those expressed or implied by such forward-looking statements. Such risks, uncertainties and factors include, but are not limited to: risks related to the development, testing, licensing, brand development, availability of packaging, intellectual property protection, reduced global commerce and reduced access to raw materials and other supplies do to the spread of the Coronavirus, the potential for not acquiring any rights as a result of the patent application and any products making use of the intellectual property may be ineffective or the company may be unsuccessful in commercializing them; and other approvals will be required before commercial exploitation of the intellectual property can happen. Demand for the company’s products, general business, economic, competitive, political and social uncertainties, delay or failure to receive board or regulatory approvals where applicable, and the state of the capital markets. Yield Growth cautions readers not to place undue reliance on forward-looking statements provided by Yield Growth, as such forward-looking statements are not a guarantee of future results or performance and actual results may differ materially. The forward-looking statements contained in this press release are made as of the date of this press release, and Yield Growth expressly disclaims any obligation to update or alter statements containing any forward-looking information, or the factors or assumptions underlying them, whether as a result of new information, future events or otherwise, except as required by law.

To view the source version of this press release, please visit https://www.newsfilecorp.com/release/60253

Cannabis

PURA Plows Forward With Farmersville Brands And Stock Dividend

Newsfile

Published

on

Dallas, Texas–(Newsfile Corp. – September 30, 2020) – Puration, Inc. (OTC Pink: PURA) management today communicated assurance that the company’s Farmersville Brands strategy to include the acquisition of 72-acre property in Farmersville, Texas and infused with a $100 million planned investment is moving forward. Management also confirms intentions to promptly execute on the distribution of a previously announced stock dividend. With both coming at the end of the third quarter, management decided to close the quarter before the definitive execution of the property acquisition and the dividend. PURA expects to make prompt definitive moves on both next week. Management is also pleased to highlight the impending initiation of a third production run this year of its EVERx CBD Sports Water in conjunction with ongoing consistent sales in the face of this year’s pandemic challenges.

For more information on Puration, visit http://www.purationinc.com

Disclaimer/Safe Harbor:

This news release contains forward-looking statements within the meaning of the Securities Litigation Reform Act. The statements reflect the Company’s current views with respect to future events that involve risks and uncertainties. Among others, these risks include the expectation that any of the companies mentioned herein will achieve significant sales, the failure to meet schedule or performance requirements of the companies’ contracts, the companies’ liquidity position, the companies’ ability to obtain new contracts, the emergence of competitors with greater financial resources and the impact of competitive pricing. In the light of these uncertainties, the forward-looking events referred to in this release might not occur. These statements have not been evaluated by the Food and Drug Administration. These products are not intended to diagnose, treat, cure, or prevent any disease.

Contact:
Puration, Inc.
Brian Shibley,
info@aciconglomerated.com
(800) 861-1350

To view the source version of this press release, please visit https://www.newsfilecorp.com/release/64943

Continue Reading

Cannabis

The Top Reasons Lithium Prices Will Soon Spike Higher Again

Newsfile

Published

on

Houston, Texas–(Newsfile Corp. – September 30, 2020) – The world could run into a massive lithium supply crunch.

Thanks in part to the electric vehicle boom that doesn’t look to cool off any time soon.

In fact, “A global push for EV adoption, helped by government subsidies and incentives, means that demand for lithium is not going away. Companies like Volkswagen, Ford, Mercedes and Amazon having started shifting their focus to electric vehicles,” reports Bloomberg.

According to the Boston Consulting Group, by 2025, EVs could account for a third of all auto sales. By 2030, EVs could surpass combustion engine vehicles with a market share of 51%.

Helping to fuel the boom, Tesla just signed a lithium ore supply deal with Piedmont Lithium.

“The initial five-year agreement implies that Piedmont will supply about a third of its planned 160,000-tonnes-per-year spodumene concentrate produce from its deposits in North Carolina. Both companies have an option to extend the deal for another five years,” added Reuters.

With demand increasing, it’s only a matter of time before lithium prices spike again.

E3 Metals Corp. (TSXV: ETMC) (OTC Pink: EEMMF) Could Be a Big Part of the Lithium Boom

E3 Metals Corp. just hosted the Energy Minister, Sonya Savage, from the Government of Alberta at the Company’s offices in Calgary.

During this visit, the government announced it has assembled a five-member panel of experts from the metals and mining industry whose strategic advice will help government unlock the province’s vast mineral potential, including lithium. The panel will support the province in its efforts to diversify its economy and become a world leader in mineral resource production.

“We are very happy to host the Minister of Energy at our offices today. This announcement solidifies the province’s commitment for the development of critical minerals. E3 Metals is on the forefront of lithium development in Alberta, a critical mineral that can be produced on the backbone of the oil industry. Alberta has a skilled energy labour force already in place that is well positioned to support an emerging minerals sector,” said Chris Doornbos, President and Chief Executive Officer of E3 Metals.

“As E3 Metals works to commercialize lithium production in Alberta, we are excited to participate in this broader effort to position Alberta as an international player in a world increasingly focused on battery materials,” he added.

In addition, according to Sonya Savage, Minister of Energy, Government of Alberta, “We (the Alberta government) need to take bold action to diversify our economy by exploring… minerals. Our government’s efforts will support the development… of the mineral sector including the ground breaking work that is being done by Alberta companies such as E3 (Metals). Our ultimate goal (is to become) a global destination for mineral investment exploration and development.”

The announcement by the province complements the Canada-U.S. Joint Action Plan on Critical Minerals Collaboration, which focuses on securing and developing critical mineral supply chains. Lithium, graphite, cobalt and rare earth elements, all of which play an important role in the production of lithium-ion batteries and the energy storage sector, are listed as critical minerals. To date, many other developed economies have put in place a critical minerals strategy including the European Union, Japan, Korea and Australia.

For more information, visit the company’s website at https://www.e3metalscorp.com

Legal Disclaimer

Except for the historical information presented herein, matters discussed in this article contain forward-looking statements that are subject to certain risks and uncertainties that could cause actual results to differ materially from any future results, performance or achievements expressed or implied by such statements. Winning Media is not registered with any financial or securities regulatory authority and does not provide nor claims to provide investment advice or recommendations to readers of this release.

For making specific investment decisions, readers should seek their own advice. Winning Media is only compensated for its services in the form of cash-based compensation. Pursuant to an agreement between Winning Media and E3 Metals Corp. Winning Media has been paid two thousand dollars for advertising and marketing services for E3 Metals Corp. We own ZERO shares of E3 Metals Corp. Please click here for full disclaimer.

Contact Information:
2818047972
ty@lifewatermedia.com

To view the source version of this press release, please visit https://www.newsfilecorp.com/release/64942

Continue Reading

Cannabis

PAOG Cannabis Pharmaceutical Research Initiative Gains New Traction

Newsfile

Published

on

Sandusky, Ohio–(Newsfile Corp. – September 30, 2020) – PAO Group, Inc. (OTC Pink: PAOG) today indicated plans to reveal new information on the Company’s initiative to expand its cannabis pharmaceutical treatment research beyond its current focus on Chronic Obstructive Pulmonary Disease (COPD).

In a media interview scheduled for release on Friday, October 2nd, PAOG Jim DiPrima will highlight a new pharmaceutical cannabis research expert resource engaged by the company to bring new industry recognized expertise to move PAOG’s cannabis pharmaceutical asset forward.

On July 30, 2020, PAOG acquired RespRx from Kali-Extracts, Inc. (OTC Pink: KALY). RespRx is a cannabis treatment under development for COPD derived from a patented cannabis extraction method – U.S. Patent No. 9,199,960 entitled “METHOD AND APPARATUS FOR PROCESSING HERBACEOUS PLANT MATERIALS INCLUDING THE CANNABIS PLANT.”

In an initial scientific evaluation as a treatment for COPD, RespRx has demonstrated effecting significant increases in respiration rate, tidal volume and inspiratory air flow rate. Overall data from the evaluation demonstrated that RespRx can significantly improve inspiratory lung functions in instances of moderate pulmonary fibrosis.

With RespRx now in house, PAOG has engaged multiple new experts from both the university and commercial medical research community to evaluate the RespRx formula, the formulation process and the test results.

The expert evaluation has reviewed RespRx in conjunction with other publicly available cannabis treatment research. Two studies in particular, both of which highlight the research behind GW Pharmaceuticals’ cannabinoid treatments, shed light on PAOG’s wider opportunity stemming from RespRx, the process to derive RespRx and the clinical trials to date behind RespRx.

One of the two studies is focused on CBD and the other on THC. The research seems to indicate CBD has both an impact on hyper-immune responses that might result in conditions like a cytokine storm which impacts many COVID-19 patients, and positive stimulation of immune responses that fight bad cells. The THC report seems to validate its ability to relieve pain, but it also indicates immune response manipulation capabilities to include anti-inflammatory reactions and the stimulation of immune responses to fight bad cells.

CBD Research – https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7173676/

THC Research – https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6219460/

In summary, existing publicly available cannabis treatment research further supports the research findings behind RespRx, and at the same time, the publicly available research sheds light on the expanded potential of PAOG’s RespRx overall technology.

The growing body of cannabis research is building convincing evidence behind how specific cannabinoids can beneficially impact specific immune responses. The research behind RespRx demonstrates how the process to derive RespRx can be manipulated to target specific cannabinoid extractions. Accordingly, as advancing cannabis research unveils further evidence behind how specific cannabinoids beneficially impact specific immune responses, PAOG is optimistic that it can utilize its overall cannabis extraction process to effectively derive formals with high concentrations of target cannabinoids. Hence, PAOG sees a more broad future of developing cannabis treatments beyond COPD.

In conjunction with PAOG’s acquisition of RespRx, the company also recently acquired a hemp cultivation business from Puration, Inc. (OTC Pink: PURA) to develop a proprietary cultivar to support PAOG’s cannabis pharmaceutical treatment objectives.

PAOG has announced plans with PURA to expand upon PAOG’s hemp cultivation business to develop a proprietary hemp cultivar. PAOG and PURA are partnering on PURA’s Farmersville Brands initiative.

PAOG’s Farmersville cultivar development operation will include a lab and an environmentally controlled indoor growing facility. PAOG is working with current cultivars to evolve and produce an ideal plant with full spectrum, high CBD yields to support ongoing RespRx development and to support future CBD pharmaceutical developments.

PAOG is exploring opportunities to engage with university research in partnership with its hemp cultivar development initiative.

PURA recently announced a year long initiative to transition PURA from a CBD sports beverage manufacturer into a hemp conglomerate built on lifestyle brand with a broad CBD consumer products reach, and a leading industrial hemp initiative. The brand name is Farmersville Brands and as part of their strategy, PURA has entered into a letter of intent (LOI) agreement to acquire 72 acers of agricultural property in Farmersville, Texas. PURA’s year long initiative includes plans to see the Farmersville Brand strategy infused with a $100 million investment.

www.paogroupinc.com

Forward-Looking Statements: Certain statements in this news release may contain forward-looking information within the meaning of Rule 175 under the Securities Act of 1933 and Rule 3b-6 under the Securities Exchange Act of 1934, and are subject to the safe harbor created by those rules. All statements, other than statements of fact, included in this release, including, without limitation, statements regarding potential future plans and objectives of the company are forward-looking statements that involve risks and uncertainties. There can be no assurance that such statements will prove to be accurate and actual results and future events could differ materially from those anticipated in such statements. Technical complications, which may arise, could prevent the prompt implementation of any strategically significant plan(s) outlined above. The Company undertakes no duty to revise or update any forward-looking statements to reflect events or circumstances after the date of this release.

CONTACT INFORMATION

Puration, Inc.
Brian Shibley,
(800) 861-1350
info@aciconglomerated.com

To view the source version of this press release, please visit https://www.newsfilecorp.com/release/64940

Continue Reading

Trending Online

Grassnews is part of PICANTE Media and Events, a leading media and boutique event organizer in the European Union with a monthly reach of +50,000 readers. The official company (PROSHIRT SRL), has been listed for 4 years in a row among the top 3 Advertising and market research agencies in the local Top Business Romania Microcompanies based on the Financial Reports. Grassnews digests / hand picks the latest news about the CBD / Legal Cannabis industry and serves them to you daily.

Contact us: sales@picante.today

Editorial / PR Submissions

© Grassnews .com 2019 - 2020 - part of PICANTE Media. All rights reserved. Registered in Romania under Proshirt SRL, Company number: 2134306, EU VAT ID: RO21343605. Office address: Blvd. 1 Decembrie 1918 nr.5, Targu Mures, Romania